Literature DB >> 31279261

Retroperitoneal Sarcomas: Does Laterality Matter?

Johanna Lou1, Ambria S Moten2, Sanjay S Reddy3, Krisha J Howell4, Sujana Movva5, Margaret von Mehren5, Jeffrey M Farma6.   

Abstract

BACKGROUND: Sarcomas are malignant tumors of connective tissue that can vary widely in etiology. Parameters such as grade, extent of resection, and tumor integrity have been shown to affect prognosis. Our principal aim was to examine associations between the laterality of retroperitoneal sarcomas and tumor characteristics, treatment, and patient outcomes.
MATERIALS AND METHODS: We performed a retrospective study of patients treated at our tertiary referral center with a diagnosis of primary retroperitoneal sarcoma who underwent tumor resection. Categorical variables were compared using the chi-square test, whereas continuous variables were compared using one-way analysis of variance. Cox regression was used to estimate the risk of death.
RESULTS: Data from 106 patients were analyzed. A greater proportion of bilateral or midline tumors were leiomyosarcomas (P = 0.02), whereas right-sided tumors were more likely to be liposarcoma (P = 0.02). There was no significant relationship between laterality and tumor grade or stage. Two-thirds of patients had at least one contiguous organ resected (n = 68, 65.4%). Patients with nephrectomy during sarcoma resection were more likely to have right-sided disease (P = 0.02). Splenectomy and pancreatectomy were associated with left-sided disease (P < 0.01; P < 0.01), and pancreaticoduodenectomies with bilateral or midline disease (P < 0.001). Adjusting for age, sex, race, grade, stage, histology, and treatment, there was no increased risk of death or recurrence based on laterality.
CONCLUSIONS: Although laterality did not seem to have a measurable relationship with patient outcomes or survival, there was a significant association between laterality, tumor histology, and resection of contiguous organs. These preliminary findings warrant further investigation.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Retroperitoneal sarcoma; Soft tissue sarcoma; Surgery

Mesh:

Year:  2019        PMID: 31279261      PMCID: PMC6815680          DOI: 10.1016/j.jss.2019.05.016

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  15 in total

1.  Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.

Authors:  A Gronchi; R Miceli; C Colombo; S Stacchiotti; P Collini; L Mariani; C Sangalli; S Radaelli; R Sanfilippo; M Fiore; P G Casali
Journal:  Ann Oncol       Date:  2011-07-16       Impact factor: 32.976

2.  Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

Authors:  Alessandro Gronchi; Dirk C Strauss; Rosalba Miceli; Sylvie Bonvalot; Carol J Swallow; Peter Hohenberger; Frits Van Coevorden; Piotr Rutkowski; Dario Callegaro; Andrew J Hayes; Charles Honoré; Mark Fairweather; Amanda Cannell; Jens Jakob; Rick L Haas; Milena Szacht; Marco Fiore; Paolo G Casali; Raphael E Pollock; Chandrajit P Raut
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

3.  Lessons learned from the study of 10,000 patients with soft tissue sarcoma.

Authors:  Murray F Brennan; Cristina R Antonescu; Nicole Moraco; Samuel Singer
Journal:  Ann Surg       Date:  2014-09       Impact factor: 12.969

4.  Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.

Authors:  Emily Z Keung; Jason L Hornick; Monica M Bertagnolli; Elizabeth H Baldini; Chandrajit P Raut
Journal:  J Am Coll Surg       Date:  2013-10-25       Impact factor: 6.113

Review 5.  Prognostic models for RPS patients-Attempting to predict patient outcomes.

Authors:  Dario Callegaro; Rosalba Miceli; Rebecca A Gladdy
Journal:  J Surg Oncol       Date:  2017-12-19       Impact factor: 3.454

6.  Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.

Authors:  J T Miura; J Charlson; T C Gamblin; D Eastwood; A Banerjee; F M Johnston; K K Turaga
Journal:  Eur J Surg Oncol       Date:  2015-07-29       Impact factor: 4.424

7.  Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.

Authors:  Alessandro Gronchi; Salvatore Lo Vullo; Marco Fiore; Chiara Mussi; Silvia Stacchiotti; Paola Collini; Laura Lozza; Elisabetta Pennacchioli; Luigi Mariani; Paolo Giovanni Casali
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

8.  Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.

Authors:  Sylvie Bonvalot; Michel Rivoire; Marine Castaing; Eberhard Stoeckle; Axel Le Cesne; Jean Yves Blay; Agnès Laplanche
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

Review 9.  Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.

Authors:  J J Lewis; D Leung; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience.

Authors:  Imran Hassan; Saung Z Park; John H Donohue; David M Nagorney; Paul A Kay; Antonio G Nasciemento; Cathy D Schleck; Duane M Ilstrup
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.